Does Improved Endothelial Vasodilator Function Matter?

From the Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md. Correspondence to Richard O. Cannon III, MD, National Institutes of Health, Bldg 10, Room 7B15, 10 Center Dr MSC-1650, Bethesda, MD 20892-1650.

E-mail [email protected] Key Words: Editorials cholesterol vasodilation endothelium statins Lipid-lowering therapy with HMG-CoA reductase inhibitors (statins) has been shown in large clinical trials to reduce cardiovascular morbidity and mortality in otherwise healthy hypercholesterolemic subjects and in patients with coronary artery disease. The magnitude of risk reduction is greatest in individuals with the highest pretreatment cholesterol levels, although those with mild elevation in LDL cholesterol may also benefit from statin therapy. Because angiographic trials with lipid-lowering therapy have shown little reduction in atherosclerotic plaque size, alternate mechanisms of therapeutic benefit to the arterial wall have been ... more.

I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.